Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Magnesium levels may be used to monitor preeclampsia patients
being treated with magnesium sulfate, although in most cases
monitoring clinical signs (respiratory rate and dep tendon reflexes) is
adequate and blood magnesium levels are not required.
Magnesium, along with potassium, is a major intracellular cation.
Magnesium is a cofactor of many enzyme systems. All
ATP-dependent enzymatic reactions require magnesium as a
cofactor. Approximately 70% of magnesium ions are stored in
bone. The remainder is involved in intermediary metabolic
processes; about 70% is present in free form, while the other 30%
is bound to proteins (especially albumin), citrates, phosphate,
and other complex forms. The serum magnesium level is kept
constant within very narrow limits. Regulation takes place mainly
via the kidneys, primarily via the ascending loop of Henle.
Conditions that interfere with glomerular filtation result in retention
of magnesium and hence elevation of serum concentrations.
Hypermagnesemia is found in acute and chronic renal failure,
magnesium overload, and magnesium release from the
intracellular space. Mild-to-moderate hypermagnesemia may
prolong atrioventricular conduction time. Magnesium toxicity may
result in central nervous system (CNS) depression, cardiac
arrest, and respiratory arrest.
Numerous studies have shown a correlation between
magnesium deficiency and changes in calcium, potassium,
and phosphate homeostasis that are associated with cardiac
disorders such as ventricular arrhythmias that cannot be
treated by conventional therapy, increased sensitivity to
digoxin, coronary artery spasms, and sudden death. Additional
concurrent symptoms include neuromuscular and neuropsychiatric
disorders. Conditions that have been associated with
hypomagnesemia include chronic alcoholism, childhood
malnutrition, lactation, malabsorption, acute pancreatitis,
hypothyroidism, chronic glomerulonephritis, aldosteronism,
and prolonged intravenous feeding.
0-15 years: Not established
> or =16 years: 1.8-2.5 mg/dL
Symptoms of magnesium deficiency do not typically appear until
levels are < or =1.0 mg/dL. Levels > or =10 mg/dL may be
life-threatening.
Normal serum magnesium levels range from 1.7-2.1 mg/dL.
Serum or plasma magnesium concentration provides only an
approximate guide to the presence or absence of magnesium
deficiency. Hypomagnesemia reliably indicates magnesium deficiency,
but its absence does not exclude significant magnesium depletion.
The concentration of magnesium in serum has not been shown to
correlate with any other tissue pools of magnesium except
interstitial fluid.
1. Tietz Textbook of Clinical Chemistry. 4th edition. Edited by
CA Burtis, ER Ashwood, and DE Bruns. Philadelphia, WB Saunders Company, 49:1893-1912, 2006
2. Ryan MF: The role of magnesium in clinical biochemistry: an
overview. Ann Clin Biochem 1991;28:19